MENU
CARM
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

CARM stock forecast, quote, news & analysis

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma’s proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases... Show more

A.I.Advisor
published price charts
Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
CARM stock forecast, quote, news & analysis